Abstract
Delusions and hallucinations are common in people with dementia,1 and although risperidone and olanzapine show efficacy for the treatment of psychosis in Alzheimer's disease, their use has been linked to cardiovascular adverse events and increased risk of death.2 Safe and effective treatments are needed when non-pharmacological interventions have been unsuccessful and symptoms continue to distress or place the patient and others at risk.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
